Latest Regulatory News

Icon Energy Limited reported a stable cash position of $431,414 at the end of June 2025, with no exploration activity during the quarter as it awaits final approval of Petroleum Lease PL-1144. The company plans to pursue joint venture partnerships once the lease is granted.

Audalia Resources has completed critical drilling programs at its Medcalf vanadium-titanium-iron project, progressing resource upgrades and mine design while managing tight cash reserves and financing arrangements.

BWP Property Group and BWP Trust have launched a new Distribution Reinvestment Plan allowing stapled securityholders to reinvest cash distributions into additional securities, potentially at a discount and without transaction costs.

Haranga Resources is poised to complete its acquisition of the Lincoln Gold Project in California, bolstered by strong due diligence results, while advancing uranium and gold exploration projects in Senegal with permit renewals and maiden drilling.

Lion Energy has made steady progress on its Port of Brisbane Green Hydrogen Project while moving closer to securing funding for a key drilling operation in Indonesia’s East Seram PSC.

Battery Age Minerals Ltd has responded to an ASX price query, denying undisclosed information and attributing recent trading activity to a new research report and the launch of its maiden drilling program.

Taruga Minerals has exercised its option to acquire 100% of the Thowagee Project in Western Australia, reporting promising high-grade polymetallic rock chip and soil sampling results that expand exploration potential.

Rey Resources reports continued exploration progress in Western Australia's Canning Basin alongside a stable financial footing supported by substantial shareholder loans.

Hot Chili Limited confirms a significant copper-gold mineralisation footprint at its La Verde discovery in Chile, completing phase-one drilling and advancing strategic funding discussions for its key projects.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.